Skip to main content
  • Retraction Note
  • Open access
  • Published:

Retraction Note: CYPA promotes the progression and metastasis of serous ovarian cancer (SOC) in vitro and in vivo

The Original Article was published on 29 November 2019

Retraction Note: J Ovarian Res 12, 118 (2019)

https://doi.org/10.1186/s13048-019-0593-2

The Editors-in-Chief have retracted this article. After publication, concerns were raised regarding highly similar images between this article and a number of other articles that were submitted and published within a close time frame [1,2,3,4,5].

The authors have stated that the image duplication occurred due to the use of a shared platform, and that the original data could not be retrieved. Due to the number and severity of the duplications, the Editors-in-Chief no longer have confidence in the presented data.

All authors agree to this retraction.

References

  1. Liu XD, Yao DW, Xin F. TTK contributes to tumor growth and metastasis of clear cell renal cell carcinoma by inducing cell proliferation and invasion. Neoplasma. 2019;66(6):946–53. https://doi.org/10.4149/neo_2019_190207N109.

    Article  CAS  PubMed  Google Scholar 

  2. Tian DW, Wu ZL, Jiang LM, Gao J, Wu CL, Hu HL. KIF5A promotes bladder cancer proliferation in vitro and in vivo. Dis Markers. 2019. https://doi.org/10.1155/2019/4824902.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Zhang J, Yin YT, Wu CH, et al. AK4 promotes the progression of HER2-positive breast cancer by facilitating cell proliferation and invasion. Dis Markers. 2019. https://doi.org/10.1155/2019/8186091.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Sun JJ, Li HL, Ma H, et al. SMYD2 promotes cervical cancer growth by stimulating cell proliferation. Cell Biosci. 2019;9:75. https://doi.org/10.1186/s13578-019-0340-9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Sun YF, Wu HL, Shi RF, Chen L, Meng C. KIF15 promotes proliferation and growth of hepatocellular carcinoma. Anal Cell Pathol. 2020. https://doi.org/10.1155/2020/6403012.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yan-Ying Xu.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Qi, ZY., Wang, F., Yue, YY. et al. Retraction Note: CYPA promotes the progression and metastasis of serous ovarian cancer (SOC) in vitro and in vivo. J Ovarian Res 16, 174 (2023). https://doi.org/10.1186/s13048-023-01267-2

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/s13048-023-01267-2